|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 302 IDR | -1.95% |
|
-6.21% | -13.22% |
| Apr. 29 | PT Suparma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 01 | PT Suparma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
PT Suparma Tbk reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was IDR 1,952,288.53 million compared to IDR 2,357,992.61 million a year ago. Net income was IDR 143,732.07 million compared to IDR 246,443.96 million a year ago.
Basic earnings per share from continuing operations was IDR 46 compared to IDR 78 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.22% | 59.33M | |
| +27.77% | 6B | |
| +32.32% | 2.69B | |
| -3.83% | 1.61B | |
| +7.53% | 1.52B | |
| -17.32% | 1.19B | |
| +18.49% | 1.03B | |
| -11.76% | 937M | |
| -17.90% | 872M | |
| -13.53% | 825M |
PT SUPARMA TBK 